- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 30, 2026 | 14.4M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 14.1M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 13.9M sh |
| Dividends Paid | Q1 2026 · Mar 31, 2026 | $1.8M |
| Dividends Paid | Q1 2026 · Mar 31, 2025 | $1.8M |
| Capex | Q1 2026 · Mar 31, 2026 | $12.5M |
| Capex | Q1 2026 · Mar 31, 2025 | $9.5M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $46.7M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $44.8M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $379.4M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $380.9M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $362.6M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $366.6M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $871.8M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $852.5M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $1.44B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $1.42B |
| Total Assets restated | Q1 2026 · Mar 31, 2025 | $1.42B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.57 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.60 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.58 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.62 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $51.7M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $48.2M |
| Net Income | Q1 2026 · Mar 31, 2026 | $8.1M |
| Net Income | Q1 2026 · Mar 31, 2025 | $8.3M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $19.7M |
| Operating Income | Q1 2026 · Mar 31, 2025 | $18.9M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $72.7M |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $68.1M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $348.3M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $337.3M |
| Revenue | Q1 2026 · Mar 31, 2026 | $421M |
| Revenue | Q1 2026 · Mar 31, 2025 | $405.4M |